Skip to main content
Clinical Trials/NCT05911854
NCT05911854CompletedNot Applicable

Efficacy of Multi-waved Locked System Laser Versus Cold Compression Therapy on Breast Cancer-related Lymphoedema: Randomized Controlled Trial

Cairo University1 site in 1 country66 target enrollmentStarted: January 21, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
66
Locations
1
Primary Endpoint
Evaluation of the change in lymphatic flow using lymphoscintigraphy pre and post treatment

Study Overview

Brief Summary

This study was conducted:

  • To investigate the effect of MLS Laser in the management of patients with unilateral BCRL regarding lymphatic flow, volumetric measurement and HRQL assessment.
  • To investigate the effect of CCT in the management of patients with unilateral BCRL regarding lymphatic flow, volumetric measurement and HRQL assessment.
  • To compare the effect of MLS Laser versus CCT in the management of patients with unilateral BCRL regarding lymphatic flow, volumetric measurement and HRQL assessment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Female patients with unilateral BCRL.
  • •Age of patients above 18 years old
  • •Patient history of modified radical mastectomy, chemotherapy and/or radiotherapy.
  • •Patients undertaken have history or current hormonal treatment.
  • •Patients with moderate lymphoedema (20-40% increase in extremity volume)

Exclusion Criteria

  • •Patients who have severe co-morbid diseases.
  • •Presence of other cancers, cancer recurrence, lymphatic malformation, or vascular disease
  • •Patients who are having current chemotherapy and/or radiotherapy.
  • •Patients who have bilateral lymphedema, current metastases, elephantiasis, infection, lymphangiosis carcinomatosa, cellulitis, venous thrombosis, or congestive heart failure
  • •Patients with musculoskeletal disorders affecting upper extremity.

Arms & Interventions

Study group (A) Multi-waved Locked System Laser group

Experimental

Intervention: Multi-waved Locked System Laser (Device)

Study group (A) Multi-waved Locked System Laser group

Experimental

Intervention: complete decongestive therapy (Other)

Study group (B) Cold Compression Therapy group

Experimental

Intervention: Cold Compression therapy (Device)

Study group (B) Cold Compression Therapy group

Experimental

Intervention: complete decongestive therapy (Other)

Group (C) Control group

Active Comparator

Intervention: complete decongestive therapy (Other)

Outcomes

Primary Outcomes

Evaluation of the change in lymphatic flow using lymphoscintigraphy pre and post treatment

Time Frame: Baseline

Interpretation of the results of the lymphoscintigraphy and using the contralateral limb as a healthy control with normal lymphatic function can differentiate the lymphatic flow abnormalities into 7 stages

The change of Volumetric measurement of the arm pre and post treatment

Time Frame: Baseline

Precise arm volume measurement is capital in the follow-up of breast cancer patients, as an early detection of BCRL can reduce the incidence of irreversible stages

Secondary Outcomes

  • The change of Lymphedema Life Impact Scale scores pre and post treatment(Baseline)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sherine Omar Abdelaziz Mohamed Elsherif

assistant lecturer

Cairo University

Study Sites (1)

Loading locations...

Similar Trials